Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GL701 for Bone Loss in SLE
NCT00053560Phase 3Unknown
- Sponsor
- Genelabs Technologies
- Start
- Dec 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of prasterone in systemic lupus erythematosus (SLE), sponsored by Genelabs Technologies. Status: unknown.
02
Drugs
prasterone
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00053560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00053560.